BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  TYME Presents Business Update and Announces Second Quarter Fiscal 2020 Conference Call and Preliminary Operational Results

  TYME Launched the Pivotal Stage of TYME-88-PANC Trial to Evaluate Oral SM-88 for Third-Line Treatment of Patients with Metastatic Pancreatic Cancer

  October 17, 2019

   · 

  10 min read
• Business

  Intuitive Announces Third Quarter Earnings

  Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced financial results for the quarter ended September 30, 2019.

  October 17, 2019

   · 

  18 min read
• Business

  Penumbra, Inc. Schedules Third Quarter 2019 Earnings Release and Conference Call for November 7, 2019

  Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2019 after market close on Thursday, November 7, 2019 at 4:30 PM Eastern Time

  October 17, 2019

   · 

  1 min read
• Job Trends

  Janssen Presents New Four-Year TREMFYA® (guselkumab) Data Demonstrating Maintained Rates of Skin Clearance in Adult Patients with Moderate to Severe Plaque Psoriasis

  At 204 weeks, patients receiving TREMFYA® in a clinical study continue to show maintained PASI 90 and IGA 0/1 responses

  October 17, 2019

   · 

  10 min read
• Biotech Bay

  DURECT to Present at Two Upcoming NASH Investor Conferences

  DURECT Corporation announced that it will be presenting at two upcoming investor conferences focused on non-alcoholic steatohepatitis

  October 17, 2019

   · 

  3 min read
• Business

  Omnicell to Release Third Quarter 2019 Earnings Results on October 24, 2019

  Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 24, 2019, to discuss the Company’s Third Quarter 2019 financial results.

  October 17, 2019

   · 

  2 min read
• Business

  Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time

  Lantheus Holdings, Inc. announced that it will host a conference call at 8:00 a.m.

  October 17, 2019

   · 

  1 min read
• Genetown

  Ironwood Pharmaceuticals to Host Third Quarter 2019 Investor Update Call

  The call will be available for replay via telephone starting October 31, 2019 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on November 14, 2019.

  October 17, 2019

   · 

  2 min read
• Drug Development

  Dermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference

  Lebrikizumab demonstrated dose-dependent improvements across endpoints spanning the range of atopic dermatitis signs and symptoms, including skin lesions and pruritus, when administered once every two or four weeks

  October 17, 2019

   · 

  13 min read
• Quotient Announces Positive Verification and Validation Results for Extended Immunohematology Microarray

  Successful Extended Immunohematology Verification and Validation data paving the way for field trials

  October 17, 2019

   · 

  2 min read